Intelligence / Healthtech / Device Recalls / Medtronic Sofamor Danek USA INC
Medtronic Sofamor Danek USA INC
21 Oct 2026: Class II recall · Grafton" DBM and Grafton Plus" DBM contain demineralized human bone tissue combined with an inert additive to yield a demineralized bone matrix (DBM) allograft . Recorded in the openFDA device enforcement reports.
- Reported
- 21 Oct 2026
- Recall Class
- Class II
- Product
- Grafton" DBM and Grafton Plus" DBM contain demineralized human bone tissue combined with an inert additive to yield a demineralized bone matrix (DBM) allograft
- Reason
- Medtronic identified through donor record review that the donor for Medtronic batch A62881 did not meet all Medtronic donor eligibility requirements related to the presence of microbial organisms. While the batch passed finished product ste
- Country
- United States
- Status
- Ongoing
- Reference
- Z-0137-2027
- Location
- Memphis, TN
A recall puts quality, regulatory, field service and communications under pressure at once.
- Class II leads with 660 of 741, then Class I (68).
- 235 added in the 30 days to 18 Nov 2026.
Find the decision makers at Medtronic Sofamor Danek USA INC
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this quality signal, for your approval.
Across AOS Research
Other records for Medtronic Sofamor Danek USA INC in our registers.
More in Class II
Device Recalls
Source: openFDA device enforcement reports, data to 18 Nov 2026. Device recalls classified by FDA, by report date. Class I is the most serious. AOS shows what the public record says; it does not verify or endorse the company.